Large-scale testing (Phase 3)UnknownNCT05096845What this trial is testingRecombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase IIIWho this might be right forCOVID-19 Pandemic Livzon Pharmaceutical Group Inc. 22,500
Testing effectiveness (Phase 2)Study completedNCT00788151What this trial is testingStudy of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsWho this might be right forDengue VirusDengue FeverDengue Hemorrhagic Fever+1 more Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT01442675What this trial is testingStudy of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra VaccineWho this might be right forMeningitisMeningococcal Infection Sanofi Pasteur, a Sanofi Company 834
Early research (Phase 1)Study completedNCT01709019What this trial is testingRSV-F Vaccine and Influenza Vaccine Co-Administration Study in the ElderlyWho this might be right forRespiratory Syncytial Virus (RSV) Novavax 220
Testing effectiveness (Phase 2)Study completedNCT02561195What this trial is testingInvestigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 YearsWho this might be right forClostridium Difficile Associated Disease Pfizer 300
Large-scale testing (Phase 3)Study completedNCT03976102What this trial is testingCompare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular LymphomaWho this might be right forFollicular Lymphoma Dr. Reddy's Laboratories Limited 317
Early research (Phase 1)Study completedNCT02537002What this trial is testingSingle Dose Study of PF-05230907 in Healthy Japanese SubjectsWho this might be right forHealthy Pfizer 17
Large-scale testing (Phase 3)UnknownNCT04536051What this trial is testingA Candidate COVID-19 Vaccine (COV003)Who this might be right forCoronavirus University of Oxford 10,300
Post-approval studies (Phase 4)UnknownNCT05460429What this trial is testingImmunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster VirusWho this might be right forVaricella Sinovac (Dalian) Vaccine Technology Co., Ltd. 37,920
Early research (Phase 1)Study completedNCT03085381What this trial is testingA Phase I Study of Quadrivalent HPV Recombinant VaccineWho this might be right forHPV Infections Shanghai Bovax Biotechnology Co., Ltd. 90
Early research (Phase 1)Study completedNCT00340431What this trial is testingExperimental Vaccine for Plasmodium Falciparum MalariaWho this might be right forPlasmodium Falciparum MalariaVaccines National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)WithdrawnNCT02180295What this trial is testingA Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)Who this might be right forHerpes Zoster Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01396512What this trial is testingStudy of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in ToddlersWho this might be right forJapanese EncephalitisJapanese Encephalitis Virus Disease Sanofi Pasteur, a Sanofi Company 274
Large-scale testing (Phase 3)Study completedNCT03614702What this trial is testingClinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPVWho this might be right forPoliomyelitis Institute of Medical Biology, Chinese Academy of Medical Sciences 1,200
Early research (Phase 1)Study completedNCT03722472What this trial is testingPhase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy AdultsWho this might be right forPulmonary TB Access to Advanced Health Institute (AAHI) 48
Testing effectiveness (Phase 2)Study completedNCT06077656What this trial is testingDose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate VaccineWho this might be right forPneumococcal Vaccines Inventprise Inc. 220
Large-scale testing (Phase 3)Study completedNCT00196937What this trial is testingHuman Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18Who this might be right forInfections, Papillomavirus GlaxoSmithKline 667
Testing effectiveness (Phase 2)Study completedNCT06582277What this trial is testingSafety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836Who this might be right forVaccine-Preventable DiseasesInfluenza Osivax 117
Early research (Phase 1)Study completedNCT01728792What this trial is testingImpact of SC vs IM Administration of DENVax (TDV) on Safety and ImmunogenicityWho this might be right forDengue Fever Takeda 80
Early research (Phase 1)Study completedNCT00000853What this trial is testingA Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 37